Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?

Article PDF
020120036_2.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Federal Practitioner
Page Number
36
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
020120036_2.pdf
Article PDF
020120036_2.pdf

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
36
Page Number
36
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media